Showing results (1-10 of 396) with videos related to
Sort By:
Pageof 40
Seminars in Cancer Biology|August 11, 2007
HLA-G expression in malignant melanomaVera Rebmann, Stefan Wagner, Hans Grosse-WildeSeminars in Cancer Biology|January 8, 2004
Secretion of sHLA-G molecules in malignanciesVera Rebmann, Jens Regel, Dietmar Stolke, et al.Human Immunology|November 7, 2003
Detection of HLA-G5 secreting cellsVera Rebmann, Annika Busemann, Monica Lindemann, et al.Seminars in Cancer Biology|August 9, 2007
HLA-G in B-chronic lymphocytic leukaemia: clinical relevance and functional implicationsVera Rebmann, Holger Nückel, Ulrich Dührsen, et al.International Journal of Cancer|July 19, 2002
Soluble HLA-DR is a potent predictive indicator of disease progression in serum from early-stage melanoma patientsVera Rebmann, Selma Ugurel, Wolfgang Tilgen, et al.Blood|October 7, 2004
HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemiaHolger Nückel, Vera Rebmann, Jan Dürig, et al.Investigative Ophthalmology & Visual Science|April 26, 2003
Expression of classic and nonclassic HLA class I antigens in uveal melanomaGerasimos Anastassiou, Vera Rebmann, Stephan Wagner, et al.American Journal of Obstetrics and Gynecology|February 20, 2003
Soluble HLA-DR levels in the maternal circulation of normal and pathologic pregnancyAndrea Steinborn, Vera Rebmann, Alexander Scharf, et al.Human Immunology|October 12, 2005
Report of the Wet Workshop for Quantification of Soluble HLA-G in Essen, 2004Vera Rebmann, Joël Lemaoult, Nathalie Rouas-Freiss, et al.Human Immunology|August 19, 2006
Soluble HLA-G in rheumatoid arthritisLeon A Verbruggen, Vera Rebmann, Christian Demanet, et al.Pageof 40